Musellim Benan, Ikitimur Hande, Uzun Hafize, Ongen Gul
Department of Pulmonary Diseases, Istanbul University, Cerrahpasa Medical Faculty, Adnan Kahveci Bulvari Rontgen sokak, No: 34/23 Bahcelievler, 34180, Istanbul, Turkey.
Rheumatol Int. 2006 Dec;27(2):163-7. doi: 10.1007/s00296-006-0184-6. Epub 2006 Sep 2.
We aimed to assess the plasma oxidant and antioxidant levels in systemic sclerosis (SS) patients with interstitial lung involvement. Twenty-seven female SS patients and 17 healthy female volunteers were included in the study. Plasma levels of oxidants and antioxidants levels were studied of two groups. The median oxidant and antioxidant levels in study and control groups were, MDA 5.2 +/- 0.4/3.7 +/- 0.5 nmol/ml (P < 0.001), NO 45.4 +/- 3.7/34.2 +/- 2.9 nmol/l (P < 0.001), SOD 25.6 +/- 2.3/24.6 +/- 2.0 U/ml (P > 0.05), catalase 99.9 +/- 9.9/140.0 +/- 10.0 U/ml (P < 0.001), vitamin E 20.5 +/- 1.3/22.6 +/- 2.0%mg (P < 0.001), vitamin C 70.6 +/- 8.7/83.5 +/- 7.3 mg/dl (P < 0.001), respectively. There was also no correlation between plasma levels of oxidants-antioxidants levels and disease duration, duration of pulmonary signs, pulmonary function test values, HRCT scores in SS patients (P > 0.05). In our study, the oxidant burden in SS patients with interstitial lung involvement was found to be increased; however no correlation was detected between the severity of lung involvement and oxidant-antioxidant levels.
我们旨在评估合并间质性肺疾病的系统性硬化症(SS)患者的血浆氧化剂和抗氧化剂水平。本研究纳入了27例女性SS患者和17名健康女性志愿者。对两组的血浆氧化剂和抗氧化剂水平进行了研究。研究组和对照组的氧化剂和抗氧化剂水平中位数分别为:丙二醛(MDA)5.2±0.4/3.7±0.5 nmol/ml(P<0.001),一氧化氮(NO)45.4±3.7/34.2±2.9 nmol/l(P<0.001),超氧化物歧化酶(SOD)25.6±2.3/24.6±2.0 U/ml(P>0.05),过氧化氢酶99.9±9.9/140.0±10.0 U/ml(P<0.001),维生素E 20.5±1.3/22.6±2.0%mg(P<0.001),维生素C 70.6±8.7/83.5±7.3 mg/dl(P<0.001)。SS患者的血浆氧化剂-抗氧化剂水平与疾病持续时间、肺部症状持续时间、肺功能测试值、高分辨率CT(HRCT)评分之间也无相关性(P>0.05)。在我们的研究中发现,合并间质性肺疾病SS患者的氧化剂负荷增加;然而,未检测到肺部受累严重程度与氧化剂-抗氧化剂水平之间的相关性。